-
Jan 6, 2022, 16:56 PM
by
X-Therma closes an oversubscribed $13M Series A financing round led by LOREA AG. Funding will advance its breakthrough product platform rewriting biopreservation and cold chain.
Full story
-
Jan 6, 2022, 16:56 PM
by
Curebase Joins WCG Avoca Quality Consortium
Full story
-
Jan 6, 2022, 16:56 PM
by
Full story
-
Jan 6, 2022, 16:56 PM
by
Bioinformatics-analysis Platform is a leading open solution for data-driven innovation, which aims to discover the hidden potential in biological data and unearth new insights or predict new prospects related to life science research. CD Genomics has recently announced Epigenetics Data Analysis to move your disease research forward.
Full story
-
Jan 6, 2022, 16:56 PM
by
Full story
-
Jan 6, 2022, 16:56 PM
by
Full story
-
Jan 6, 2022, 16:56 PM
by
Qlucore, provider of intuitive bioinformatics software for research and precision and companion diagnostics, announces the creation of a Scientific Advisory Board (SAB), consisting of five members, chaired by Carl-Johan Ivarsson, CEO of Qlucore.
Full story
-
Jan 6, 2022, 16:56 PM
by
Full story
-
Jan 6, 2022, 16:56 PM
by
Full story
-
Jan 6, 2022, 01:00 AM
by
User Not Found
Bio-IT World | All new multiple myeloma patients being treated at the Tisch Cancer Institute at Mount Sinai are now being assigned to one of 12 subgroups based on shared genetic and molecular features of their disease. The multiple myeloma patient similarity network (MM-PSN) is one of the latest computational modeling tools being used here to translate clinical data into better treatment decision-making in the clinic, and the first to apply multiomics to the stratification of patients with the blood cancer.
Full story
-
Jan 5, 2022, 01:00 AM
by
User Not Found
Bio-IT World | A large-scale study involving more than 2,000 individuals across three countries could help disentangle associations between cardiometabolic disease, the gut microbiome, and metabolic markers in the blood—and, perhaps most importantly, the potential role played by the most prescribed drug treatments.
Full story
-
Jan 3, 2022, 16:22 PM
by
User Not Found
Bio-IT World | Data aggregation and consolidation are essential in biopharmaceutical development. Research teams use a wide range of analytical and sensor data from various instruments, which are often spread across multiple sites. These data streams need a common platform to allow scientists to review the data and make decisions. Excel is used to perform this consolidation in many companies, but while access to Excel is convenient, this software is the root cause of many data management problems.
Full story
-
Dec 28, 2021, 01:00 AM
by
User Not Found
Bio-IT World | AI used in talent engagement and communication and in the development of therapeutic antibodies; women’s health, maternal health, and contraceptive technologies
Full story
-
Dec 27, 2021, 01:00 AM
by
User Not Found
Bio-IT World | Some of our biggest stories of the year were about the promise to limit aging through epigenetic reprogramming, new inhibitors to prevent age-associated cognitive decline, and improved single-cell sequencing technologies. Of course interest in COVID-19 remained, and we went in depth on mRNA vaccines and talked digital transformation at Pfizer and GSK in this pandemic era.
Full story
-
Dec 22, 2021, 01:00 AM
by
User Not Found
Bio-IT World | Singular Genomics launches new benchtop sequencer, collaborations in neuropsychiatry, lactation research, skin health, chronic pain, and SARS-CoV-2 vaccines, Insilico Medicine announces first-in-human trial of an AI-developed drug. Plus new products from PerkinElmer, Thermo Fisher, Genomenon, and more.
Full story
-
Dec 21, 2021, 09:27 AM
by
User Not Found
Bio-IT World | Sudeshna Das directs the data core of the Massachusetts Alzheimer’s Disease Research Center (MADRC). She recently sat down with BioTeam to discuss how MGH is collecting and working with enormous datasets to push back against Alzheimer’s.
Full story
-
Dec 16, 2021, 01:00 AM
by
User Not Found
Bio-IT World | Last week, Recursion announced two collaborations: a new collaboration with Roche and Genentech to leverage technology-enabled drug discovery through the Recursion Operating System (OS), and an expansion of an existing Bayer collaboration focused on inferential search.
Full story
-
Dec 15, 2021, 01:00 AM
by
User Not Found
Bio-IT World | A growing number of companies are endeavoring to replicate the success of gene sequencing juggernaut Illumina in the burgeoning field of proteomics. A top contender is Nautilus Biotechnology, which has spent the past few years drumming up excitement about the potential for comprehensively profiled proteins to make therapeutic and diagnostic development more effective and time efficient.
Full story
-
Dec 14, 2021, 01:00 AM
by
User Not Found
Bio-IT World | Seven Bridges Genomics has launched a new subsidiary, the Unified Patient Network (UPN), to facilitate clinical research and collaboration between participating health systems and biopharma companies. The UPN will combine de-identified sequencing data and EHR content for five million patients and allow biopharma companies to license cohorts from that dataset for research. Licensing fees from biopharma will fund the network.
Full story
-
Dec 10, 2021, 01:00 AM
by
User Not Found
Bio-IT World | The demand for proteomics studies has increased in recent years, with growing emphasis on datasets capturing vast amounts of proteomics data from large cohorts of patients, with thousands of proteins measured in each person. In part, this has been led by developments in computational methods, like deep learning to analyze data, as well as advancements in sample analytical methodologies.
Full story